Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03181932
Recruitment Status : Recruiting
First Posted : June 9, 2017
Last Update Posted : September 25, 2019
Sponsor:
Information provided by (Responsible Party):
Savara Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2020
Estimated Study Completion Date : September 30, 2020